
	July 4, 2025				December 31, 2024
	Current		Noncurrent		Current		Noncurrent
	(In thousands)
Accrued taxes and deferred tax liabilities	$	49,712	$	158,224	$	46,395	$	151,642
Compensation and related benefits	74,320		53,401		80,451		48,350
Asbestos liability	41,966		231,075		40,779		253,287
Contract liabilities	25,075		—		26,390		—
Lease liabilities	20,893		65,347		21,459		66,042
Warranty liability	13,268		—		12,794		—
Third-party commissions	14,099		—		17,346		—
Restructuring liability	5,606		—		4,732		374
Accrued interest	9,093		—		8,077		—
Other	41,172		67,244		40,135		13,241
	$	295,204	$	575,291	$	298,558	$	532,936

A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Condensed Balance Sheets is as follows:


	Six Months Ended
	July 4, 2025		June 28, 2024
	(In thousands)
Warranty liability, beginning of period	$	12,794	$	12,606
Accrued warranty expense	4,428		6,693
Changes in estimates related to pre-existing warranties	697		1,074
Cost of warranty service work performed	(6,125)		(5,529)

Foreign exchange translation effect and other	1,474		(298)
Warranty liability, end of period	$	13,268	$	14,546

The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated and Condensed Balance Sheets is as follows:


	Six Months Ended July 4, 2025
	Balance at Beginning of Period		Charges		Payments		Foreign Currency Translation		Balance at End of Period
	(In thousands)
Restructuring and other related charges:
Termination benefits(1)	$	3,845	$	4,401	$	(4,012)	$	691	$	4,925
Facility closure costs and other(2)	1,261		1,488		(1,878)		(190)		681
	$	5,106	$	5,889	$	(5,890)	$	501	$	5,606

(2) Includes the cost of relocating associates, relocating equipment and other costs in connection with the closure and optimization of facilities and product lines.